Human Urinary kallidinogenase promotes good recovery in ischemic stroke patients with level 3 hypertension

AIM: To evaluate the clinical efficacy of Human Urinary kallidinogenase (HUK) in the treatment of acute ischemic stroke (AIS) patients with level 3 hypertension. METHODS: In this retrospective study, from January 2015 to June 2016, 150 consecutive AIS patients were registered in our database. Among...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Danhong, Lyu, Yi, Zhong, Ping, Liu, Fengdi, Liu, Xueyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561313/
https://www.ncbi.nlm.nih.gov/pubmed/28828213
http://dx.doi.org/10.1002/brb3.752

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561313/
https://www.ncbi.nlm.nih.gov/pubmed/28828213
http://dx.doi.org/10.1002/brb3.752

Ejemplares similares